Hologic Acquires Biolucent
By HospiMedica staff writers
Posted on 01 Oct 2007
Hologic, Inc. (Bedford, MA, USA), a leading provider of diagnostic imaging and state-of-the-art digital imaging systems directed towards women's health, has completed the acquisition of BioLucent, Inc. (Aliso Viejo, CA, USA), the developer and marketer of the MammoPad breast cushion. Posted on 01 Oct 2007
"This acquisition reflects our continued strategy and efforts to offer a comprehensive portfolio of products to serve in the breast cancer detection market, ” said Jack Cumming, chairman and chief executive officer. "The BioLucent MammoPad was designed to benefit women undergoing mammograms by providing more comfort, we believe, better tissue acquisition, and ultimately improved outcomes. It is our hope, with proper training and support the MammoPad can become a standard of care in mammography. We look forward to the opportunities that will develop from this combination as we continue to build value for our shareholders.”
BioLucent's MammoPad decreases the discomfort associated with mammography. BioLucent's primary research and development efforts are directed at its brachytherapy business, which is focused on breast cancer therapy. Prior to the acquisition, BioLucent completed the spin-off of its brachytherapy technology and business to the holders of BioLucent's outstanding shares of capital stock. The new company, Cianna Medical, will manufacture and market the SAVI applicator. As a result, Hologic acquired BioLucent's Mammopad business and related assets.
The aggregate purchase price paid by Hologic to the security holders of BioLucent at the closing of the acquisition, exclusive of certain transaction costs and expenses, was approximately US$70 million, of which amount $65 million was paid by Hologic in shares of Hologic's common stock.
"We are pleased we have finalized this agreement with Hologic,” said Steven Gex, president and CEO of Biolucent, Inc. "We believe Hologic's experience and ability to work with partners to drive the adoption of value-added products in the sales channel will serve as the perfect compliment to our MammoPad breast cushion.”
Hologic is a leading developer, manufacturer, and supplier of medical imaging systems dedicated to serving the healthcare needs of women, and a leading developer of digital imaging technology for general radiography and mammography applications. Hologic's core business units are focused on osteoporosis assessment, mammography, and breast biopsy, direct-to-digital X-ray for general radiography applications, and mini C-arm imaging for orthopedic applications.
Related Links:
Hologic
Biolucent